IHR — Impact Healthcare REIT Income Statement
0.000.00%
Last trade - 00:00
- £374.59m
- £550.44m
- £50.53m
- 87
- 74
- 75
- 95
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 24.2 | 31.2 | 36.9 | 42.9 | 50.5 |
Cost of Revenue | |||||
Gross Profit | 24 | 30.8 | 36.4 | 42.2 | 49.7 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | -4.23 | -0.098 | 1.73 | 23.9 | -6.53 |
Operating Profit | 28.5 | 31.3 | 35.2 | 19.1 | 57.1 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 26.3 | 28.8 | 32 | 16.9 | 48.8 |
Provision for Income Taxes | |||||
Net Income After Taxes | 26.3 | 28.8 | 32 | 16.9 | 48.8 |
Net Income Before Extraordinary Items | |||||
Net Income | 26.3 | 28.8 | 32 | 16.9 | 48.8 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 26.3 | 28.8 | 32 | 16.9 | 48.8 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.107 | 0.09 | 0.094 | 0.043 | 0.118 |
Dividends per Share |